Recruiting Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis NCT06549231 Conditions Interstitial Lung Disease With Systemic Sclerosis Locations CHU Tours — Tours, France View Trial Details
Active, Not Recruiting A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis NCT06329401 Conditions Alveolitis, Extrinsic Allergic, Fibrosis, Hypersensitivity, +18 more Locations University of Alabama at Birmingham — Birmingham, Alabama, United States Mayo Clinic- Scottsdale — Scottsdale, Arizona, United States University of Southern California — Los Angeles, California, United States Cedars-Sinai — Los Angeles, California, United States View all 154 locations View more locations Show fewer locations Loading locations... View Trial Details
